AE Alert is Prism Science’s adverse event detection and reporting product*. It surpasses the shortcomings of literature surveillance and conventional pharmacovigilance literature surveillance, as conducted by the pharmaceutical industry today. First, AE Alert draws from a much broader circle of medical journals—not just a prestigious core set. Second, it mines the under-leveraged or ignored ‘archive’ of timely medical conference papers. Third, by leveraging AI, it complements human manual content review—in a scenario where time is critical. AE Alert doesn’t substitute automation for human-performed surveillance. It leverages technology and algorithms to expand the volume and diversity of sources, while accelerating the review process, so that pharmaceutical companies can coordinate with regulatory authorities, modify label information, and alert healthcare professions about product updates when necessary—much faster. This keeps patients safe and allows companies to predict and reduce risks by identifying emerging signals in real time and offers a streamlined, efficient and compliant approach.